This quarterly report provides an overview of pharmaceutical market performance across the Middle East and Africa in Q3 2023. It analyzes growth trends, country-level dynamics, and therapeutic area performance, highlighting variations in access, demand, and policy environments. The report examines drivers such as population growth, epidemiological shifts, pricing controls, and healthcare investment. IQVIA data and forecasts support strategic planning for manufacturers operating in or entering MEA markets, offering insights into both short-term performance and longer-term opportunity.

Join for free to read